OABI · NASDAQ · Biotechnology

OmniAb (OABI)

Provides antibody-discovery technologies that feed partner drug programs and royalty economics.

$4.81
vs last close+0.23 (+4.94%)
  1. OmniAb Raises 2026 Financial Guidance

    Business WireGuidance